We examine the combined effect of venetoclax and NaB on another type of leukemia using K562 chronic myeloid leukemia (CML) cell line expressing BCR-ABL fusion protein by t(9;22) chromosome translocation. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.